Intravenous immunoglobulin (IVIG) has been reported to be effective at reversing B19 parvovirus-associated anaemia.

Combination antiretroviral therapy may assist in the clearance of B19 parvovirus following acute infection and restore immune responses to chronic B19 parvovirus infection (Taguchi; Chen).